First-in-Class Immuno-Oncology Drug APG157DS Repolarizes Innate Immune Cells and Induces Durable Remission in a Syngeneic Glioblastoma Model
- DOI
- 10.3390/ijms27156687
- Published
- 2026-07-27
- Container
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27156687,
title = {First-in-Class Immuno-Oncology Drug APG157DS Repolarizes Innate Immune Cells and Induces Durable Remission in a Syngeneic Glioblastoma Model},
author = {Shubhasmita Mohapatra and Adrian Guerrero and Neha Rahman and Stefan Markovic and Lauren O’Donnell and Youssef Zaim Wadghiri and Khondoker Takia Zaman and Luis Avila and Parag Mehta and Probal Banerjee},
year = {2026},
journal = {International Journal of Molecular Sciences},
doi = {10.3390/ijms27156687},
url = {https://doi.org/10.3390/ijms27156687}
}RIS
TY - JOUR TI - First-in-Class Immuno-Oncology Drug APG157DS Repolarizes Innate Immune Cells and Induces Durable Remission in a Syngeneic Glioblastoma Model AU - Shubhasmita Mohapatra AU - Adrian Guerrero AU - Neha Rahman AU - Stefan Markovic AU - Lauren O’Donnell AU - Youssef Zaim Wadghiri AU - Khondoker Takia Zaman AU - Luis Avila AU - Parag Mehta AU - Probal Banerjee PY - 2026 JO - International Journal of Molecular Sciences DO - 10.3390/ijms27156687 UR - https://doi.org/10.3390/ijms27156687 ER -
APA
Mohapatra, S., Guerrero, A., Rahman, N., Markovic, S., O’Donnell, L., Wadghiri, Y. Z., Zaman, K. T., Avila, L., Mehta, P., & Banerjee, P. (2026). First-in-Class Immuno-Oncology Drug APG157DS Repolarizes Innate Immune Cells and Induces Durable Remission in a Syngeneic Glioblastoma Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27156687
Source records
- crossref · retrieved 2026-09-25T23:00:00.016Z